IASO Biotherapeutics
Focused on the discovery, development and commercialization of cell therapies in the field of oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
$540m (Public information from Jan 2023)
Jiangsu China (HQ), Nanjing China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | Series A | |
* | $60.0m | Series B | |
$108m | Series C | ||
* | $73.9m Valuation: $540m | Series C | |
* | N/A | - | |
| Total Funding | $242m | ||
Related Content
Recent News about IASO Biotherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.